[Effects of PS-K as adjuvant therapy for primary lung cancer--an autopsy case].
A 57-year-old woman underwent left lower lobectomy for primary lung cancer (papillary adenocarcinoma, T2NOMO). Despite postoperative adjuvant immunochemotherapy with 5-Fu, Carboquone and PS-K, bone metastases were recognized at 9 months after the surgery. She received radiation therapy and was administered PS-K alone, 3.0 g daily. As a result, long-term good condition was maintained with a positive PPD skin test. The bone metastases developed slowly, and the patient survived 5 years and 8 months after the operation. At autopsy, no obvious metastatic lesions were identified except for the bone metastases. The cause of her death was thought to be acute renal failure due to severe hemorrhage from an esophageal ulcer. Moreover, she was doomed because of advanced polycystic disease.
D000231:Adenocarcinoma, Papillary / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D008875:Middle Aged; D011509:Proteoglycans / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D011509:Proteoglycans; C010770:polysaccharide-K